← FDA Drug Approvals (Drugs@FDA)
TASCENSO ODT
NDA · New Drug Application · Sponsor: CYCLE · Approved 2022-12-09
Drug application
- FDA Application #
NDA214962- Application type
- New Drug Application
- Brand name
- TASCENSO ODT
- Generic name
- FINGOLIMOD LAURYL SULFATE
- Active ingredients
- FINGOLIMOD LAURYL SULFATE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CYCLE
- Manufacturer
- Cycle Pharmaceuticals Ltd
- First approval
- 2022-12-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown